PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20159692-4	2010	RESULTS: Compared with the control group, high-concentration FK506 (20 ng/ml) significantly inhibited the secretions of IL-2, IL-6, IL-12, IL-17, IFN-gamma, TNF-alpha, GM-CSF and G-CSF.	Tacrolimus	61-66	colony stimulating factor 3	Homo sapiens	179-184	
20159692-6	2010	CONCLUSION: FK506 effectively inhibits the secretion of proinflammatory cytokines including IL-6, IFN-gamma and TNF-alpha and also the secretion of IL-2, IL-12, IL-17, GM-CSF and G-CSF.	Tacrolimus	12-17	colony stimulating factor 3	Homo sapiens	179-184	
12605126-0	2003	Facilitation of tacrolimus-induced heart-allograft acceptability by pretransplant host treatment with granulocyte colony-stimulating factor: interleukin-12-restricted suppression of intragraft monokine mRNA expression.	Tacrolimus	16-26	colony stimulating factor 3	Homo sapiens	102-139	
12668156-1	2003	Pretransplant treatment of recipients with recombinant human granulocyte colony-stimulating factor (rhG-CSF, 250 microg/kg/day s.c. for 5 days) facilitates heart allograft acceptance in tacrolimus-treated rat recipients.	Tacrolimus	186-196	colony stimulating factor 3	Homo sapiens	61-98	
7613145-3	1995	The immunosuppressive agents CsA and FK506 enhanced the release of leukotriene B4 (LTB4) from human neutrophil granulocytes dependent on the priming with G-CSF and IL-3.	Tacrolimus	37-42	colony stimulating factor 3	Homo sapiens	154-159